Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · IEX Real-Time Price · USD

1.540

-0.060 (-3.75%)

At close: Apr 25, 2024, 4:00 PM

1.550

+0.010 (0.65%)

After-hours: Apr 25, 2024, 7:59 PM EDT

Lexicon Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1998
Cash & Equivalents	22.47	46.35	64.07	126.26	36.11	80.39	61.66	46.6	202.99	137.27	Upgrade
Short-Term Investments	147.56	92.01	22.68	26.01	235.55	79.67	249.13	299.9	318.36	202.07	Upgrade
Cash & Cash Equivalents	170.03	138.36	86.74	152.28	271.66	160.05	310.79	346.5	521.35	339.34	Upgrade
Cash Growth	22.89%	59.50%	-43.04%	-43.95%	69.73%	-48.50%	-10.31%	-33.54%	53.64%	162.79%	Upgrade
Receivables	1.01	0.03	0.01	0.4	56.53	5.92	4.83	7.49	0.91	1.04	Upgrade
Inventory	0.38	0	0	0	4.24	4.68	1.95	0	0	0	Upgrade
Other Current Assets	5.13	2.48	2.16	5.05	5.32	2.67	4.43	3.88	10.14	28.61	Upgrade
Total Current Assets	176.55	140.87	88.92	157.72	337.75	173.32	322	357.87	532.4	368.99	Upgrade
Property, Plant & Equipment	7.51	8.48	3.45	0.3	14.05	15.87	17.69	19.39	21.23	1.08	Upgrade
Goodwill and Intangibles	44.54	44.54	44.54	44.54	64.26	94.66	96.43	97.9	97.9	97.9	Upgrade
Other Long-Term Assets	0.83	0.41	0	1.23	1.66	0.29	0.43	0.46	0.43	3.41	Upgrade
Total Long-Term Assets	52.88	53.43	47.99	46.07	79.96	110.81	114.54	117.75	119.56	102.39	Upgrade
Total Assets	229.43	194.3	136.91	203.79	417.72	284.14	436.54	475.63	651.96	471.38	Upgrade
Accounts Payable	14.39	10.4	9.15	5.47	12.18	12.05	38.76	52.88	19.73	13.06	Upgrade
Deferred Revenue	0	0	0	0	0	25.99	65.25	112.31	185.65	14.3	Upgrade
Current Debt	0	0	0	11.65	11.01	1.12	14.09	16.28	1.98	20.17	Upgrade
Other Current Liabilities	17.16	12.78	12.97	29.69	42.15	-2.41	-12.62	-16.82	-84.39	-2.56	Upgrade
Total Current Liabilities	31.55	23.17	22.12	46.81	65.34	36.75	105.49	164.64	122.96	44.97	Upgrade
Long-Term Debt	104.77	54	1.19	0	234.17	243.89	231.58	85.17	100.96	87.5	Upgrade
Other Long-Term Liabilities	0	0	0	0.61	1.1	29.9	31.21	68.41	142.19	54.89	Upgrade
Total Long-Term Liabilities	104.77	54	1.19	0.61	235.27	273.79	262.79	153.58	243.15	142.39	Upgrade
Total Liabilities	136.32	77.18	23.31	47.42	300.61	310.54	368.27	318.22	366.11	187.36	Upgrade
Total Debt	104.77	54	1.19	11.65	245.18	245	245.67	101.45	102.94	107.67	Upgrade
Debt Growth	94.01%	4438.07%	-89.78%	-95.25%	0.07%	-0.27%	142.17%	-1.45%	-4.39%	392.15%	Upgrade
Retained Earnings	-1,766.84	-1,589.72	-1,487.78	-1,400.02	-1,341.44	-1,471.58	-1,365.24	-1,250.36	-1,108.93	-1,104.25	Upgrade
Comprehensive Income	0.03	-0.43	-0.01	-0.01	0.08	-0.01	-0.22	-0.2	-0.22	-0.06	Upgrade
Shareholders' Equity	93.11	117.12	113.6	156.37	117.1	-26.41	68.27	157.4	285.85	284.02	Upgrade
Net Cash / Debt	65.25	84.35	85.55	140.63	26.48	-84.95	65.12	245.06	418.42	231.67	Upgrade
Net Cash / Debt Growth	-22.64%	-1.40%	-39.16%	431.16%	-	-	-73.43%	-41.43%	80.61%	116.01%	Upgrade
Net Cash Per Share	0.30	0.51	0.59	1.27	0.23	-0.80	0.62	2.36	4.04	3.03	Upgrade
Working Capital	145	117.69	66.8	110.91	272.41	136.57	216.51	193.23	409.44	324.02	Upgrade
Book Value Per Share	0.42	0.71	0.78	1.41	1.10	-0.25	0.65	1.51	2.76	3.72	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).